Onartuzumab (Anti-HGFR / c-Met) | c-Met | Read Reviews & Product Use Citations

Onartuzumab (Anti-HGFR / c-Met) is a unique, humanized and affinity-matured monovalent (one-armed) monoclonal antibody against the MET receptor. Onartuzumab potently inhibits HGF binding and receptor phosphorylation and signaling. Onartuzumab has antibody-like pharmacokinetics and antitumor activity. MW: 144.64 KD.

Click to purchase the isotype control of Onartuzumab (Anti-HGFR / c-Met)

Purity & Quality Control

Batch: A246801 Purity: 99% Protein concentration: 5.76mg/ml Endotoxin Level: ＜1EU/mg

99

Choose Selective c-Met Inhibitors

Biological Activity

Description	Onartuzumab (Anti-HGFR / c-Met) is a unique, humanized and affinity-matured monovalent (one-armed) monoclonal antibody against the MET receptor. Onartuzumab potently inhibits HGF binding and receptor phosphorylation and signaling. Onartuzumab has antibody-like pharmacokinetics and antitumor activity. MW: 144.64 KD.

Product Details

CAS No.	1133766-06-9
Molecular Weight	144.64 kDa
Isotype	Human IgG1
Source	CHO
Purification	AKTA
Sterility	0.2 μM filtered
Formulation	100mMPro-Ac,20mMArg-Ac，pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field